Ditchcarbon
  • Customers
  1. Organizations
  2. Trianni, Inc.
Public Profile
Research Pending

This profile hasn't yet passed our validation checks

Submit your email to push it up the queue

We'll prioritize this organization's research and notify you when detailed sustainability data becomes available.

Pharmaceutical Preparation Manufacturing
US
updated 13 days ago

Trianni, Inc.

Company website

Trianni, Inc., a leading innovator in the biotechnology sector, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2011, the company has established itself as a pioneer in the development of advanced antibody discovery technologies, particularly through its proprietary Trianni Mouse platform. Trianni's core offerings include high-quality monoclonal antibodies that are uniquely engineered for specificity and efficacy, catering to the needs of researchers in pharmaceuticals and diagnostics. The company has achieved notable milestones, including collaborations with major pharmaceutical firms, solidifying its position as a trusted partner in the biopharmaceutical industry. With a commitment to scientific excellence and innovation, Trianni, Inc. continues to drive advancements in therapeutic development and research applications.

DitchCarbon Score

How does Trianni, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

29

Industry Benchmark

Trianni, Inc.'s score of 25 is lower than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.

44%

Let us know if this data was useful to you

Trianni, Inc.'s reported carbon emissions

Trianni, Inc., headquartered in the US, currently does not have specific carbon emissions data available, as indicated by the absence of reported figures. The company is a current subsidiary of AbCellera Biologics Inc., which may influence its climate commitments and reporting practices. While there are no documented reduction targets or climate pledges from Trianni, Inc., it is important to note that the company is part of a broader corporate family that may have its own sustainability initiatives. As such, any climate commitments or emissions data may be inherited from its parent organisation, AbCellera Biologics Inc., which could potentially have its own strategies for addressing carbon emissions. In the absence of specific emissions data or reduction initiatives, Trianni, Inc. is positioned within an industry context that increasingly prioritises sustainability and climate action. The company may benefit from aligning with industry standards and practices to enhance its environmental performance in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Trianni, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Trianni, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Trianni, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ligand Pharmaceuticals Incorporated

US
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Ablexis, LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Kymab Limited

GB
•
Research and development services (73)
Updated 3 days ago

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250918.5
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy